These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 25516667)
21. Serum Interleukin-33 level in Saudi children with inflammatory bowel disease. Saadah OI; Al-Harthi SE; Al-Mughales JA; Bin-Taleb YY; Baeshen RS Int J Clin Exp Pathol; 2015; 8(12):16000-6. PubMed ID: 26884875 [TBL] [Abstract][Full Text] [Related]
22. Influence of urban/rural and coastal/inland environment on the prevalence, phenotype, and clinical course of inflammatory bowel disease patients from northwest of Spain: a cross-sectional study. Carpio D; Barreiro-de Acosta M; Echarri A; Pereira S; Castro J; Ferreiro R; Lorenzo A; Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1030-7. PubMed ID: 26049704 [TBL] [Abstract][Full Text] [Related]
23. A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis. Mantzaris GJ; Sfakianakis M; Archavlis E; Petraki K; Christidou A; Karagiannidis A; Triadaphyllou G Am J Gastroenterol; 2004 Jun; 99(6):1122-8. PubMed ID: 15180735 [TBL] [Abstract][Full Text] [Related]
24. Long-term assessment of clinical response to adalimumab therapy in refractory ulcerative colitis. Hussey M; Mc Garrigle R; Kennedy U; Holleran G; Kevans D; Ryan B; Breslin N; Mahmud N; McNamara D Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):217-21. PubMed ID: 26587866 [TBL] [Abstract][Full Text] [Related]
25. Presenting features and disease course of pediatric ulcerative colitis. Aloi M; D'Arcangelo G; Pofi F; Vassallo F; Rizzo V; Nuti F; Di Nardo G; Pierdomenico M; Viola F; Cucchiara S J Crohns Colitis; 2013 Dec; 7(11):e509-15. PubMed ID: 23583691 [TBL] [Abstract][Full Text] [Related]
30. Clinical presentation and disease course of inflammatory bowel disease differs by race in a large tertiary care hospital. Sofia MA; Rubin DT; Hou N; Pekow J Dig Dis Sci; 2014 Sep; 59(9):2228-35. PubMed ID: 24752402 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of infliximab in treating patients with ulcerative colitis: experiences from a single medical center in southern China. Zhou YL; Xie S; Wang P; Zhang T; Lin MY; Tan JS; Zhi FC; Jiang B; Chen Y J Dig Dis; 2014 Sep; 15(9):483-90. PubMed ID: 24828856 [TBL] [Abstract][Full Text] [Related]
32. Granulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease. De Cassan C; Savarino E; Marson P; Tison T; Hatem G; Sturniolo GC; D'Incà R World J Gastroenterol; 2014 Dec; 20(45):17155-62. PubMed ID: 25493030 [TBL] [Abstract][Full Text] [Related]
33. Factors associated with exacerbation of newly diagnosed mild ulcerative colitis based on a nationwide registry in Japan. Kuwahara E; Murakami Y; Nakamura T; Inoue N; Nagahori M; Matsui T; Watanabe M; Suzuki Y; Nishiwaki Y J Gastroenterol; 2017 Feb; 52(2):185-193. PubMed ID: 27075755 [TBL] [Abstract][Full Text] [Related]
34. A Study of the Epidemiology, Clinical, and Phenotypic Characteristics of Inflammatory Bowel Disease in the Northen-Central Region of Saudi Arabia. Al-Fawzan AA; Al-Radhi SA; Al-Omar AS; Al-Mutiri NH; Al-Ammari AM; El-Gohary M; Shamsan AN; Al Shehri HM; ALGhasab NS Diagnostics (Basel); 2023 Jun; 13(13):. PubMed ID: 37443529 [TBL] [Abstract][Full Text] [Related]
35. Comparing the clinical outcomes of young-onset and adult-onset ulcerative colitis: a multi-center Korean Association for the Study for Intestinal Diseases study. Kim JY; Park DI; Han DS; Huh KC; Lee CK; Shin JE; Kim JH; Kim YS; Jung Y; Jung SA; Song HJ; Jang HJ; Kim YH; Hong SN Korean J Intern Med; 2017 Jan; 32(1):69-78. PubMed ID: 27338135 [TBL] [Abstract][Full Text] [Related]
36. Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry. Bokemeyer B; Hardt J; Hüppe D; Prenzler A; Conrad S; Düffelmeyer M; Hartmann P; Hoffstadt M; Klugmann T; Schmidt C; Weismüller J; Mittendorf T; Raspe H J Crohns Colitis; 2013 Jun; 7(5):355-68. PubMed ID: 22503168 [TBL] [Abstract][Full Text] [Related]
37. The Demographic and Clinical Characteristics of Ulcerative Colitis in a Northeast Brazilian Population. da Silva BC; Lyra AC; Mendes CM; Ribeiro CP; Lisboa SR; de Souza MT; Portela RC; Santana GO Biomed Res Int; 2015; 2015():359130. PubMed ID: 26509150 [TBL] [Abstract][Full Text] [Related]
38. E-health: Web-guided therapy and disease self-management in ulcerative colitis. Impact on disease outcome, quality of life and compliance. Elkjaer M Dan Med J; 2012 Jul; 59(7):B4478. PubMed ID: 22759851 [TBL] [Abstract][Full Text] [Related]
39. Oral tacrolimus as maintenance therapy for refractory ulcerative colitis--an analysis of outcomes in two London tertiary centres. Landy J; Wahed M; Peake ST; Hussein M; Ng SC; Lindsay JO; Hart AL J Crohns Colitis; 2013 Dec; 7(11):e516-21. PubMed ID: 23623737 [TBL] [Abstract][Full Text] [Related]
40. The severity of inflammation at onset of ulcerative colitis is not associated with IBS-like symptoms during clinical remission. Jonefjäll B; Simrén M; Öhman L; Lasson A; Svedlund J; Strid H J Crohns Colitis; 2015 Sep; 9(9):776-83. PubMed ID: 26079726 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]